226400 — Osteonic Co Income Statement
0.000.00%
- KR₩137bn
- KR₩136bn
- KR₩34bn
- 50
- 28
- 65
- 46
Annual income statement for Osteonic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12,615 | 15,598 | 19,839 | 27,799 | 34,235 |
Cost of Revenue | |||||
Gross Profit | 5,495 | 6,502 | 8,730 | 13,051 | 16,741 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 15,610 | 16,101 | 18,708 | 23,453 | 27,405 |
Operating Profit | -2,996 | -503 | 1,131 | 4,346 | 6,829 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6,495 | -5,438 | 2,081 | 1,781 | 6,639 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5,381 | -2,852 | 836 | 3,658 | 5,650 |
Net Income Before Extraordinary Items | |||||
Net Income | -5,381 | -2,852 | 836 | 3,658 | 5,650 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -5,381 | -2,852 | 100 | 3,658 | 5,653 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -259 | -135 | 30.8 | 209 | 287 |
Dividends per Share |